Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 16, 2014
Antigen dependently activated cluster of differentiation 8-positive T cells cause perforin-mediated neurotoxicity in experimental strokeEva Mracsko, Arthur Liesz, Ana Stojanovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2016
Impact of Blood-Brain Barrier Integrity on Tumor Growth and Therapy Response in Brain MetastasesMatthias Osswald, Jonas Blaes, Yunxiang Liao, et al.
Nature Communications|February 13, 2021
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in gliomaErik Jung, Matthias Osswald, Miriam Ratliff, et al.
The Journal of Clinical Investigation|January 3, 2015
Proximity ligation assay evaluates IDH1R132H presentation in gliomasLukas Bunse, Theresa Schumacher, Felix Sahm, et al.
Molecular Cancer Therapeutics|January 27, 2016
Bevacizumab Prevents Brain Metastases Formation in Lung AdenocarcinomaAysegül Ilhan-Mutlu, Matthias Osswald, Yunxiang Liao, et al.
Oncotarget|February 17, 2015
Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastomaTobias Kessler, Felix Sahm, Jonas Blaes, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2013
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitisTobias V Lanz, Simon Becker, Matthias Osswald, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2017
Tweety-Homolog 1 Drives Brain Colonization of GliomasErik Jung, Matthias Osswald, Jonas Blaes, et al.
Neuro-Oncology|June 19, 2023
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progressionMiriam Ratliff, Kianush Karimian-Jazi, Dirk C Hoffmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2013
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapyMarkus Weiler, Jonas Blaes, Stefan Pusch, et al.
Pageof 3